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INTRODUCTION 
NASA is focusing on long-duration missions on the International Space Station (ISS) and future exploration-class 
missions beyond low-Earth orbit. Visual acuity changes observed after short-duration missions were largely 
transient, but more than 50% of ISS astronauts experienced more profound, chronic changes with objective 
structural and functional findings such as papilledema and choroidal folds. Globe flattening, optic nerve sheath 
dilation, and optic nerve tortuosity also are apparent. This pattern is referred to as the visual impairment and 
intracranial pressure (VIIP) syndrome. VIIP signs and symptoms, as well as postflight lumbar puncture data, suggest 
that elevated intracranial pressure (ICP) may be associated with the spaceflight-induced cephalad fluid shifts, but 
this hypothesis has not been tested. The purpose of this study is to characterize fluid distribution and 
compartmentalization associated with long-duration spaceflight, and to correlate these findings with vision changes 
and other elements of the VIIP syndrome. We also seek to determine whether the magnitude of fluid shifts during 
spaceflight, as well as the VIIP-related effects of those shifts, is predicted by the crewmember’s preflight conditions 
and responses to acute hemodynamic manipulations (such as head-down tilt). Lastly, we will evaluate the patterns of 
fluid distribution in ISS astronauts during acute reversal of fluid shifts through application of lower body negative 
pressure (LBNP) interventions to characterize and explain general and individual responses.  
  
METHODS 
We will examine a variety of physiologic variables in 10 long-duration ISS crewmembers using the test conditions 
and timeline presented in the Figure below. Measures include: (1) fluid compartmentalization (total body water by 
D2O, extracellular fluid by NaBr, intracellular fluid by calculation, plasma volume by CO rebreathe, interstitial fluid 
by calculation); (2) forehead/eyelids, tibia, calcaneus tissue thickness (by ultrasound); (3) vascular dimensions by 
ultrasound (jugular veins, cerebral and carotid arteries, vertebral arteries and veins, portal vein); (4) vascular 
dynamics by MRI (head/neck blood flow, cerebrospinal fluid pulsatility); (5) ocular measures (optical coherence 
tomography, intraocular pressure, 2-dimensional ultrasound including optic nerve sheath diameter, globe flattening, 
and retina-choroid thickness, Doppler ultrasound of ophthalmic and retinal arteries, and veins); (6) cardiac variables 
by ultrasound (inferior vena cava, tricuspid flow and tissue Doppler, pulmonic valve, stroke volume, right heart 
dimensions and function, four-chamber views); and (7) ICP measures (tympanic membrane displacement, 
distortion-product otoacoustic emissions, and ICP calculated by MRI). On the ground, acute head-down tilt will 
induce cephalad fluid shifts, whereas LBNP will oppose these shifts. Controlled Mueller maneuvers will manipulate 
cardiovascular variables. Through interventions applied before, during, and after flight, we intend to fully evaluate 
the relationship between fluid shifts and the VIIP syndrome.  
 
DISCUSSION 
Six crewmembers have consented to participate in this experiment.  The first two are currently inflight, with the 
others in preflight testing and training.  The first two subjects are projected to complete testing in 2016 with the 
entire complement of subjects completed by 2018.  
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